NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...
Many clinical trials to test the use of psychedelic medicines for conditions such as depression have been underway since 2022 ...
A veteran of the Iraq and Afghanistan wars, Dervaes had one foot in the grave before contacting Ambio Life Sciences. Two ...
Marc Dervaes journeyed to Mexico for a psychedelic drug that more military veterans are hoping will relieve their trauma.
With plans in place to launch global pivotal testing of GH-001, its inhaled version of psychedelic mebufotenin (5-MeO-DMT), in treatment-resistant depression in 2026, GH Research plc reported the ...
The California Department of Public Health has warned consumers not to eat TRE House brand "Magic Mushroom" gummies, ...
On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, ...
PATRICK COX was the A-list shoe designer who hit rock bottom. Now 'Party Pat' tells YOU about finding peace on the iconic ...
11d
Court finds insufficient evidence Taflyn Fiola aided husband Laszlo Fiola’s alleged drug trafficking
A magistrate has thrown out serious drug charges faced by a Gold Coast marriage celebrant who police claimed aided her ...
The Exploration Target is estimated to be between 40 and 50 million tonnes of mineralization grading between 0.80% and 1.10% Li2O and between 120ppm and 145ppm Ta2O5 and is largely constrained to the ...
GH Research's stock rallied after saying the FDA lifted a hold on its experimental depression treatment The FDA lifted its hold on GH Research's psychedelic drug, sending the company's shares soaring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback